cohort based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnostic codes. With robust statistical methodology and after adjusting for important confounders, they found that OSA was independently associated with increased odds ratio (OR) for the composite outcome of major postoperative adverse events (OR 1.47; 95% confidence interval [CI], 1.39-1.55). Not surprisingly, the association was stronger with pulmonary complications (OR 1.86; 95% CI, 1.65-2.09) than cardiac complications (OR 1.59; 95% CI, 1.48-1.71) with the risk of cardiac complications mainly due to atrial fibrillation. It is interesting to note that this type of arrhythmia has been strongly associated with OSA in nonsurgical cohorts as well. 13 The risk of emergent reintubation was significantly increased in patients with OSA (OR 10.26; 95% CI, 9.01-11.69). OSA patients without hypertension and chronic obstructive pulmonary disease were 14 times more likely to receive mechanical ventilation and 46 times more likely to undergo noninvasive ventilation (NIV) than non-OSA patients. OSA was also independently associated with escalation of care, increased health care resource utilization, and length of stay. 12 The types of complications associated with OSA reported by Memtsoudis et al. are similar to the findings from a recent analysis of the Nationwide Inpatient Sample. 14 In the study by Memtsoudis et al., 12 despite the increased rates of complications, there was no significant increase in the risk of in-hospital mortality in patients with OSA. In patients undergoing elective surgeries and bariatric surgeries, OSA was also found not to be associated with increased in-hospital mortality.
14,15 D'Apuzzo and Browne 16 examined a cohort of 258,488 patients undergoing revision total hip arthroplasty or total knee arthroplasty surgeries between 2006 and 2008. Contrary to these studies, OSA was associated with increase in-hospital mortality (OR 1.9; 95% CI, 1.3-2.8) with a mortality of 0.2% in patients without OSA www.anesthesia-analgesia.org aNEsthEsia & aNalgEsia and 0.4% in patients with OSA. 16 However, this study only included patients undergoing revision arthroplasty that may suggest a higher comorbidity burden.
So what do these results tell us? First and foremost, it appears that OSA is consistently and independently associated with increased postoperative respiratory failure, requiring NIV or invasive mechanical ventilation, pulmonary complications, and atrial fibrillation. 4, 8, 12, [14] [15] [16] Second, despite an increase in adverse events and resource utilization, OSA does not appear to be associated with increased risk of inhospital mortality with the exception of revision total hip or revision total knee arthroplasty. 12, [14] [15] [16] One can only speculate as to why increased postoperative complications do not lead to an increase in in-hospital mortality. A few possibilities include obesity paradox or ischemia preconditioning, playing a protective role. [17] [18] [19] [20] It is also possible that OSA patients with impending respiratory failure were recognized earlier, and definitive treatment (i.e., endotracheal intubation or NIV) was implemented in a more timely fashion. Indeed, Mokhlesi et al. 14, 15 reported that in the subgroup of postoperative patients who were emergently reintubated, reintubation occurred significantly earlier in OSA patients. Another speculation is that some of the patients without a diagnosis of OSA may have had unrecognized OSA, leading to an underestimation of mortality rates. [5] [6] [7] Indeed, studies using cohorts from databases to identify OSA patients are bound to include only those patients with diagnosed OSA, leaving us to wonder whether outcomes in undiagnosed patients may be worse. Irrespective of the reasons for these findings, however, one should not lose sight of the fact that mortality is a rare outcome in total hip and knee arthroplasties and that other more frequently encountered complications, although less severe, may be more relevant drivers of medical decision making and resource utilization.
Most large administrative databases lack longitudinal data, therefore, limiting inferences about outcomes after hospital discharge. A recent observational cohort study of 14,962 patients undergoing elective surgery at a single institution over a 4-year period also did not find an independent association between having high risk for OSA and 30-day or 1-year mortality. 21 However, there is overwhelming evidence from longitudinal community and clinic-based studies that untreated severe OSA is an independent predictor of mortality. 22, 23 Since most patients with clinically significant OSA remain undiagnosed, anesthesiologists can have a pivotal role in recognizing these patients and referring them for clinical evaluation. [5] [6] [7] Recent studies have indeed shown that continuous positive airway pressure (CPAP) can effectively treat OSA during the perioperative period, 24 decrease the risk of postoperative emergent intubation, 25 and have a beneficial long-term effect. 26 However, it is important to note that adherence to CPAP therapy during the perioperative period is suboptimal, and there is a need to explore ways to improve compliance to CPAP and explore alternative treatment modalities. 24, 27, 28 Notwithstanding the strengths of the study by Fleischut et al., 12 there are several limitations that are inherent to the analysis of any large administrative database. 29 Undoubtedly, prospective multicenter practice-based evidence study design or randomized controlled trials, albeit challenging, would provide superior evidence and establish the direction of causality. The results of these desperately needed trials will also provide guidance for protocol developments that are supported by evidence and not by opinions. [30] [31] [32] [33] [34] In the meantime, Memtsoudis et al. 12 have provided us with incremental evidence warranting such clinical trials in the near future. We believe that such significant increases in adverse postoperative outcomes in patients with diagnosed OSA is a wake-up call for all stakeholders (i.e., patients, patient advocates, health care providers, hospital administrators, policy makers, and funding agencies). Without collective support, we will continue to lack the high level of evidence needed to guide us in providing the best possible perioperative care to our surgical patients. E DISCLOSURES Name: Frances Chung, MBBS, FRCPC.
